Veltkamp and colleagues reported a decrease in the frequency of regulatory T cells in the peripheral blood and an increased frequency in mucosal lymphoid tissues in IBD patients with active disease; this decrease was partially reversed with anti-TNFα treatment and a decrease in disease activity [55]. Here, TNF is linked to inflammatory bowel disease.